Kaposiform Hemangioendothelioma Pediatric Research and Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Vascular Anomalies Center

Kaposiform hemangioendothelioma research & clinical trials

Physicians and researchers at Boston Children’s Vascular Anomalies Center have generated an extensive database of cases of vascular anomalies, including more than 250 cases of KHE. We are actively evaluating the best therapies for KHE and studying long- term outcomes after KHE. As our database grows, it will help shine more light on this rare and often misunderstood condition.

Consolidating knowledge about KHE treatment, side effects and outcomes in this database will help us treat children more effectively. Based on this database, we have recently published a paper on 107 children referred to the VAC, providing insight into unusual presentations of this rare disease.

In 2015 we opened a clinical trial comparing vincristine and sirolimus in patients with KHE complicated by KMP. This randomized, controlled, multicenter trial involving several institutions around the country will answer questions about which of these medications is a better treatment for KHE.

Kaposiform hemangioendothelioma: Reviewed by Cameron C. Trenor III, MD, © Boston Children's Hospital, 2016

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337